Top 10 Companies in the Standard Metling Agarose Market (2026): Market Leaders Driving Global Life Sciences

MARKET INSIGHTS

The Standard Melting Agarose market was valued at USD 56.2 million in 2024 and is projected to rise to USD 86.4 million by 2032, reflecting a steady expansion driven by research and diagnostic demand.

Standard Melting Agarose is a high‑purity polysaccharide extracted from seaweed, prized for its consistent gelling properties that enable precise DNA and RNA separation in gel electrophoresis. The product line includes low‑melting‑point and high‑resolution grades, each engineered for specific laboratory workflows.

Growth momentum stems from escalating R&D investments in genomics and proteomics, with the global genomics market expected to reach USD 94.6 billion by 2030. The surge in COVID‑19 testing and other nucleic‑acid diagnostics has amplified consumption, while key manufacturers are scaling production—Lonza announced a 30 % output boost at its North American facility, and Thermo Fisher Scientific and Bio‑Rad Laboratories continue to innovate high‑performance formulations.

Standard Metling Agarose Market – View in Detailed Research Report

Market Size

In 2025, the Standard Melting Agarose market reached USD 59.8 million. Forecasts for 2026 place the value at USD 63.2 million, while projections for 2034 anticipate a rise to USD 110.5 million, underscoring sustained demand across life‑science sectors.

Product Definition

Standard Melting Agarose is engineered to provide a clear, reproducible gel matrix that maintains integrity during melting and re‑solidification, making it ideal for nucleic‑acid analysis, diagnostic workflows, and protein purification processes.

Top 10 Companies in the Standard Metling Agarose Market

1. Lonza (Switzerland)

Headquarters: Basel, Switzerland
Key Offering: SeaKem LE and GTG Agarose, tailored for high‑resolution electrophoresis and protein purification.
Lonza’s recent 30 % capacity expansion at its North American plant positions it to meet growing biopharma demand. The company prioritizes sustainability through responsible seaweed sourcing and invests in automated production lines to reduce energy consumption.
• 30 % output increase in 2025
• Focus on renewable raw‑material procurement
• Development of low‑cost, high‑purity grades for emerging markets

2. Thermo Fisher Scientific (United States)

Headquarters: Waltham, USA
Key Offering: Thermo Scientific Agarose, featuring advanced low‑background staining compatibility.
Thermo Fisher’s continuous product innovation supports rapid assay turnaround, and its global distribution network ensures consistent supply. The firm is advancing carbon‑neutral manufacturing initiatives and expanding digital lab integration tools.
• Global supply chain optimization
• Digital workflow solutions for electrophoresis
• Carbon‑neutral production targets by 2035

3. Bio‑Rad Laboratories (United States)

Headquarters: Hercules, USA
Key Offering: Bio‑Rad Agarose, known for exceptional clarity and low‑melting‑point performance.
Bio‑Rad emphasizes R&D in high‑resolution gels for next‑generation sequencing prep and invests in modular production units that lower waste. The company partners with academic consortia to drive standardization in nucleic‑acid assays.
• Modular production units
• Academic partnership programs
• Low‑background staining technology

4. Hispanagar (Spain)

Headquarters: Barcelona, Spain
Key Offering: Hispanagar SeaKem series, tailored for research and diagnostic laboratories.
Hispanagar focuses on cost‑effective production for emerging markets and has launched a sustainable seaweed cultivation program in the Mediterranean. The firm is expanding its digital sales platform to reach global customers.
• Mediterranean seaweed cultivation
• Digital B2B sales platform
• Cost‑effective grade development

5. Laboratorios CONDA (Spain)

Headquarters: Barcelona, Spain
Key Offering: CONDA Agarose, engineered for high‑purity applications in biopharma.
Laboratorios CONDA partners with contract research organizations to provide customized gel solutions and invests in green chemistry to reduce solvent use. The company is scaling up its production capacity to serve the EU market.
• Custom gel solutions for CROs
• Green chemistry initiatives
• EU market expansion

6. Amresco (United States)

Headquarters: North Carolina, USA
Key Offering: Amresco Agarose, designed for routine electrophoresis with a focus on affordability.
Amresco’s lean manufacturing model supports rapid scaling, and the company is piloting biodegradable packaging to align with sustainability trends.
• Lean manufacturing
• Biodegradable packaging pilot
• Affordable grade development

7. Biotools (Spain)

Headquarters: Madrid, Spain
Key Offering: Biotools Agarose, offering high‑purity grades for biopharmaceutical workflows.
Biotools collaborates with pharmaceutical firms to tailor gel formulations for antibody purification and invests in quality‑by‑design manufacturing processes.
• Collaboration with pharma firms
• Quality‑by‑design manufacturing
• Tailored gel formulations

8. Biskanten (South Korea)

Headquarters: Seoul, South Korea
Key Offering: Biskanten Agarose, optimized for high‑resolution DNA analysis.
With a strong foothold in the Asian market, Biskanten is expanding its R&D to develop gels compatible with automated electrophoresis systems and is pursuing eco‑friendly sourcing strategies.
• R&D for automated systems
• Eco‑friendly sourcing
• Asian market expansion

9. Sigma‑Aldrich (United States)

Headquarters: St. Louis, USA
Key Offering: Sigma‑Aldrich Agarose, recognized for its consistent performance in molecular biology.
The company is enhancing its supply chain resilience and investing in next‑generation gel chemistries that reduce background noise.
• Supply chain resilience
• Next‑generation gel chemistries
• Noise reduction technology

10. Merck KGaA (Germany)

Headquarters: Darmstadt, Germany
Key Offering: Merck Agarose, offering high‑purity grades for diagnostics and research.
Merck is leveraging its extensive research network to develop gels for single‑cell analysis and is pursuing carbon‑neutral manufacturing practices.
• Single‑cell analysis gels
• Carbon‑neutral manufacturing
• Extensive research network

Download FREE Sample Report: Standard Metling Agarose Market – View in Detailed Research Report

Get Full Report: Standard Metling Agarose Market – View in Detailed Research Report

Outlook

The Standard Melting Agarose market is set to grow from USD 59.8 million in 2025 to USD 110.5 million by 2034, driven by expanding genomics research, diagnostic adoption, and biopharmaceutical protein purification needs. The market will continue to benefit from technological advancements in gel chemistry and automation, while sustainability initiatives will shape production strategies.

Future Trends

Key emerging trends include the integration of agarose gels with automated imaging platforms, the development of hybrid gels that combine standard melting properties with fluorescence compatibility, and the expansion of educational and training kits that leverage ready‑to‑use agarose solutions. Companies that align their product portfolios with these trends and invest in sustainable manufacturing will likely capture the largest share of the growing market.